Oragenics OGEN Stock
Oragenics Price Chart
Oragenics OGEN Financial and Trading Overview
| Oragenics stock price | 0.59 USD |
| Previous Close | 0.55 USD |
| Open | 0.57 USD |
| Bid | 0 USD x 10000 |
| Ask | 0 USD x 40000 |
| Day's Range | 0.57 - 0.61 USD |
| 52 Week Range | 0.5 - 4.19 USD |
| Volume | 70.8K USD |
| Avg. Volume | 61.62K USD |
| Market Cap | 2.61M USD |
| Beta (5Y Monthly) | 1.264 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.95 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
OGEN Valuation Measures
| Enterprise Value | -3443032 USD |
| Trailing P/E | N/A |
| Forward P/E | -0.05351852 |
| PEG Ratio (5 yr expected) | -8.96 |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.40905875 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Oragenics Stock Price History
| Beta (5Y Monthly) | 1.264 |
| 52-Week Change | -83.93% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 4.19 USD |
| 52 Week Low | 0.5 USD |
| 50-Day Moving Average | 0.61 USD |
| 200-Day Moving Average | 0.88 USD |
OGEN Share Statistics
| Avg. Volume (3 month) | 61.62K USD |
| Avg. Daily Volume (10-Days) | 46.33K USD |
| Shares Outstanding | 4.51M |
| Float | 4.42M |
| Short Ratio | 14.07 |
| % Held by Insiders | 1.92% |
| % Held by Institutions | 5.76% |
| Shares Short | 708.93K |
| Short % of Float | 15.73% |
| Short % of Shares Outstanding | 15.70% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:30 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -105.55% |
| Return on Equity (ttm) | -311.00000000000000000000000000000000% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -2696586 USD |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -9826737 USD |
| Diluted EPS (ttm) | -4.95 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 6.11M USD |
| Total Cash Per Share (mrq) | 1.35 USD |
| Total Debt (mrq) | 56.13K USD |
| Total Debt/Equity (mrq) | 0.91 USD |
| Current Ratio (mrq) | 5.727 |
| Book Value Per Share (mrq) | 1.413 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -9334941 USD |
| Levered Free Cash Flow (ttm) | -5872412 USD |
Profile of Oragenics
| Country | United States |
| State | FL |
| City | Lakewood Ranch |
| Address | 9015 Town Center Parkway |
| ZIP | 34202 |
| Phone | 813 286 7900 |
| Website | https://www.oragenics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 3 |
Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical therapies neurological conditions and infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid, which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification for the treatment of mild traumatic brain injury. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Lakewood Ranch, Florida.
Q&A For Oragenics Stock
What is a current OGEN stock price?
Oragenics OGEN stock price today per share is 0.59 USD.
How to purchase Oragenics stock?
You can buy OGEN shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Oragenics?
The stock symbol or ticker of Oragenics is OGEN.
Which industry does the Oragenics company belong to?
The Oragenics industry is Biotechnology.
How many shares does Oragenics have in circulation?
The max supply of Oragenics shares is 4.51M.
What is Oragenics Price to Earnings Ratio (PE Ratio)?
Oragenics PE Ratio is now.
What was Oragenics earnings per share over the trailing 12 months (TTM)?
Oragenics EPS is -4.95 USD over the trailing 12 months.
Which sector does the Oragenics company belong to?
The Oragenics sector is Healthcare.
Oragenics OGEN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NYSE American Composite Index
XAX
US
|
7941.57 USD — |
-0.43
|
— — | — — | — — | — - | — — |
- {{ link.label }} {{link}}